Literature DB >> 26403263

FGF2 Overrides TGFβ1-Driven Integrin ITGA11 Expression in Human Dermal Fibroblasts.

Alexandra Grella1, Denis Kole1, William Holmes1, Tanja Dominko1,2.   

Abstract

Deposition of collagen-based extracellular matrix by fibroblasts during wound healing leads to scar formation--a typical outcome of the healing process in soft tissue wounds. The process can, however, be skewed in favor of tissue regeneration by manipulation of wound environment. Low oxygen conditions and supplementation with FGF2 provide extracellular cues that drive wound fibroblasts towards a pro-regenerative phenotype. Under these conditions, fibroblasts dramatically alter expression of many genes among which the most significantly deregulated are extracellular matrix and adhesion molecules. Here we investigate the mechanism of a collagen I binding integrin α11 (ITGA11) deregulation in response to low oxygen-mediated FGF2 effects in dermal fibroblasts. Using RT-PCR, qRT-PCR, Western blotting, and immunocytochemistry, we describe significant down-regulation of ITGA11. Decrease in ITGA11 is associated with its loss from focal adhesions. We show that loss of ITGA11 requires FGF2 induced ERK1/2 activity and in the presence of FGF2, ITGA11 expression cannot be rescued by TGFβ1, a potent activator of ITGA11. Our results indicate that FGF2 may be redirecting fibroblasts towards an anti-fibrotic phenotype by overriding TGFβ1 mediated ITGA11 expression.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  FIBROBLAST; FIBROBLAST GROWTH FACTOR; HYPOXIA; INTEGRIN ITGA11; TRANSFORMING GROWTH FACTOR β

Mesh:

Substances:

Year:  2015        PMID: 26403263     DOI: 10.1002/jcb.25386

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  8 in total

1.  FGF2-mediated attenuation of myofibroblast activation is modulated by distinct MAPK signaling pathways in human dermal fibroblasts.

Authors:  David M Dolivo; Sara A Larson; Tanja Dominko
Journal:  J Dermatol Sci       Date:  2017-09-01       Impact factor: 4.563

Review 2.  Fibroblast Growth Factor 2 as an Antifibrotic: Antagonism of Myofibroblast Differentiation and Suppression of Pro-Fibrotic Gene Expression.

Authors:  David M Dolivo; Sara A Larson; Tanja Dominko
Journal:  Cytokine Growth Factor Rev       Date:  2017-09-23       Impact factor: 7.638

3.  Half-life modeling of basic fibroblast growth factor released from growth factor-eluting polyelectrolyte multilayers.

Authors:  Ivan Ding; Amy M Peterson
Journal:  Sci Rep       Date:  2021-05-07       Impact factor: 4.379

4.  MicroRNA-222 regulates the viability of fibroblasts in hypertrophic scars via matrix metalloproteinase 1.

Authors:  Yi Zhang; Xiaohua Lin; Li Zhang; Weilong Hong; Kang Zeng
Journal:  Exp Ther Med       Date:  2017-12-14       Impact factor: 2.447

5.  Transcriptome analysis of basic fibroblast growth factor treated stem cells isolated from human exfoliated deciduous teeth.

Authors:  Nunthawan Nowwarote; Jeeranan Manokawinchoke; Kiattipan Kanjana; Benjamin P J Fournier; Waleerat Sukarawan; Thanaphum Osathanon
Journal:  Heliyon       Date:  2020-06-25

6.  MicroRNA-663 regulates the proliferation of fibroblasts in hypertrophic scars via transforming growth factor-β1.

Authors:  Qi Chen; Tianlan Zhao; Xiaoming Xie; Daojiang Yu; Lijun Wu; Wenyuan Yu; Wei Sun
Journal:  Exp Ther Med       Date:  2018-06-22       Impact factor: 2.447

Review 7.  In search of definitions: Cancer-associated fibroblasts and their markers.

Authors:  Martin Nurmik; Pit Ullmann; Fabien Rodriguez; Serge Haan; Elisabeth Letellier
Journal:  Int J Cancer       Date:  2019-02-28       Impact factor: 7.396

8.  Crosstalk between mitogen-activated protein kinase inhibitors and transforming growth factor-β signaling results in variable activation of human dermal fibroblasts.

Authors:  David M Dolivo; Sara A Larson; Tanja Dominko
Journal:  Int J Mol Med       Date:  2018-10-23       Impact factor: 4.101

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.